Antimicrobial resistance and the environment: assessment of advances, gaps and recommendations for agriculture, aquaculture and pharmaceutical manufacturing

• DOI: 10.1093/femsec/fix185
• Publication Date: 2017-12-22T00:00:07Z
• Authors: Edward Topp; D G Joakim Larsson; Daniel N Miller; Chris Van den Eede; Marko P J Virta
• Keywords: Pharmaceutical Manufacturing

A roundtable discussion held at the fourth International Symposium on Environmental Dimension of Antibiotic Resistance (EDAR4) considered key issues concerning impact environment antibiotic use in agriculture and aquaculture, emissions from manufacturing. The critical control points for reducing antibiotics are stewardship pre-treatment manure sludge to abate antibiotic-resistant bacteria. Antibiotics sometimes added fish shellfish production sites via feed, representing a direct route contamination aquatic environment. Vaccination reduces need high value (e.g. salmon) systems. Consumer regulatory pressure will over time contribute emission very concentrations Research priorities include development technologies, practices incentives that allow effective reduction use, together with evidence-based standards residues effluents. All relevant stakeholders be aware threat antimicrobial resistance apply best practice agriculture, aquaculture pharmaceutical manufacturing order mitigate development. policy mitigation must cognizant varied challenges facing low income countries.